Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-((8-((tert-butyldimethylsilyl)oxy)quinolin-5-yl)sulfonyl)-1,3-diphenylpropane-1,3-dione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1421355-33-0

Post Buying Request

1421355-33-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-((8-((tert-butyldimethylsilyl)oxy)quinolin-5-yl)sulfonyl)-1,3-diphenylpropane-1,3-dione

    Cas No: 1421355-33-0

  • Need to discuss

  • No requirement

  • Adequate

  • LEAP CHEM Co., Ltd.
  • Contact Supplier

1421355-33-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1421355-33-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,1,3,5 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1421355-33:
(9*1)+(8*4)+(7*2)+(6*1)+(5*3)+(4*5)+(3*5)+(2*3)+(1*3)=120
120 % 10 = 0
So 1421355-33-0 is a valid CAS Registry Number.

1421355-33-0Relevant articles and documents

Design, synthesis, anti-schistosomal activity and molecular docking of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives

Eweas, Ahmad F.,Allam, Gamal,Abuelsaad, Abdelaziz S.A.,Alghamdi, Abdul Hamid,Maghrabi, Ibrahim A.

, p. 17 - 25 (2013)

Schistosomiasis remains one of the most prevalent parasitic infections and has significant public health consequences. Praziquantel (PZQ) is the only drug currently administrated to treat this disease. However, praziquantel-resistant parasites have been identified in endemic areas and can be generated in the laboratory. Therefore, it is essential to find new therapeutics. Herein we report a series of novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives, which were synthesized, characterized and tested as anti-schistosomal agents in vitro. Among all tested compounds, compounds 4a, 5b, and 7b at different tested concentrations (50, 100, and 200 μg/mL) showed the highest schistosomicidal activity. Among those 3 compounds, compound 7b was the most potent anti-schistosomal one. Moreover, all tested compound, at 50 μg/mL concentration, significantly reduced oviposition of adult worms in vitro. Furthermore, both compound 4a and 7b, as well as compound 6a, completely diminished egg deposition. To clarify the possible mechanism by which novel 8-hydroxyquinoline-5-sufonyl 1,4-diazepine derivatives act as anti-schistosomal agents, molecular docking of all new compounds was carried out using Molsoft ICM pro 3.5-0a to investigate the binding affinity and binding mode to thioredoxin glutathione reductase enzyme (TGR), a potential drug target for anti-schistosomal agents. The docking results revealed moderate to high affinity of the new compounds towards TGR. Compound 7b scored the highest binding energy (-101.13 kcal/mol) against TGR crystal structure forming eight hydrogen bonds with the amino acid residues at the binding site of the receptor. This result indicates that compound 7b could exert its effect through inhibition of TGR, which is a vital enzyme for schistosome survival.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1421355-33-0